XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.1

Shareholders' Equity (Deficit):

3 Months Ended

Mar. 29, 2025

Shareholders' Equity (Deficit):

Shareholders' Equity (Deficit):

8. Shareholders’ Equity (Deficit):

​

Dividends

​

On January 29, 2025, the Company’s Board of Directors approved the payment of a $0.90 per share quarterly cash dividend to shareholders of record at the close of business on February 12, 2025, which was paid on March 3, 2025.

​

Repurchase of Common Stock

​

During the first three months of 2025, the Company repurchased 7,383 shares of its common stock. Under the Board of Directors’ authorization, as of March 29, 2025, the Company has the ability to repurchase an additional 71,217 shares of its common stock. Repurchases may be made from time to time at prevailing prices, subject to certain restrictions on volume, pricing and timing.

​

Stock Option Plans and Stock-Based Compensation

​

Stock option activity under the Company’s option plans as of March 29, 2025 was as follows:

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​	​		Weighted Average		​	​
​	​	​	​	​	​	​	Remaining	​	​	​
​	​	Number of	​	Weighted Average		​	Contractual Life	​	​	​
​		Shares		Exercise Price			(years)			Intrinsic Value
Outstanding, December 28, 2024		319,844	​	$	203.89	​	​	​	​	​
Exercised		(210)	​	​	227.17	​	​	​	​	​
Outstanding, March 29, 2025		319,634	​	$	203.88	​	5.46	​	$	37,610,500
Exercisable, March 29, 2025		234,846	​	$	174.20	​	4.57	​	$	33,157,000

​

No options were granted during the first three months ended March 29, 2025 or the three months ended March 30, 2024. All unexercised options at March 29, 2025 have an exercise price equal to the fair market value on the date of the grant.

​

Compensation expense of $536,600 and $485,900 relating to the vested portion of the fair value of stock options granted was expensed to “Selling, General and Administrative Expenses” in the first three months of 2025 and 2024, respectively. As of March 29, 2025, the Company had $4.0 million of total unrecognized compensation expense related to stock options that is expected to be recognized over the remaining weighted average vesting period of approximately 2.0 years.

​

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/718/tableOfContent

+ Details

Name:	us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration